NANKAI CHEMICAL COMPANY,LIMITED Q4 FY2025 earnings call

2025 March Term Consolidated Performance

• Consolidated revenue reached 20.9 billion yen, operating profit 1.306 billion yen, ordinary profit 1.456 billion yen, and net income attributable to parent shareholders 1.015 billion yen. Revenue was nearly in line with plan, as weak demand for electrolytic products was offset by strong sales in the various salts business.
• Operating profit beat plan by 22%, and ordinary profit beat plan by 21.3%, driven by strong performance of the various salts business. This marked year-on-year revenue growth but profit decline, as higher wages, logistics costs, and raw material prices offset top-line growth from strong salt sales.

Balance Sheet and Cash Flow Updates

• Fixed assets increased due to deferred land preparation and soil improvement costs related to a subsidiary's planned land sale; these costs will be reclassified from assets to expenses at the scheduled November 2025 handover.
• Interest-bearing debt increased due to strategic accumulation of long-term debt at favorable rates to prepare for coming interest rate hikes. The equity ratio rose to 37.4%, indicating continued improvement in financial health.
• Operating cash flow declined year-on-year due to soil improvement payments for the land sale and timing differences in accounts payable settlements. A 1.5 billion yen deposit from the land sale was recorded in investing cash flow, resulting in negative free cash flow for the year, but management confirmed no liquidity issues.

Strategic and Operational Updates

• FY2026 is the second year of the mid-term management plan, with core priorities of strengthening the earnings base, expanding the environmental recycling business, and advancing sustainable management. The year is positioned as a preparation period for future growth, with three key expansion initiatives for environmental recycling: expanding waste sulfur recycling alongside existing waste sulfuric acid processing, improving impurity removal capacity to support business growth, and scaling up the desalination business. Investment decisions for these initiatives are underway.
• Nankai Chemical absorbed NC Environment Co., Ltd. via merger on April 1, 2025. The merger aims to eliminate waste, improve operational efficiency, speed up decision-making, combine resources and shared assets, and support faster sustainable growth of the high-priority environmental recycling segment.
• Capital expenditure plans maintain the prior 3-year target of 100 billion yen total investment from FY2024 to FY2026 (30 billion yen to 40 billion yen annually). FY2025 investment was lower than planned due to project delays, but investment will proceed as scheduled over the remaining two years of the plan.

Dividend Policy

• The company changed its dividend policy to include an interim dividend starting in the FY2024 March term, and has increased the annual dividend annually: 50 yen in FY2024, 55 yen in FY2025. The company targets stable dividends with continued increases and higher payout ratios over time.

1. Chemicals Business:

• Against plan: Overall revenue came in slightly below plan, due to lower demand for electrolytic products and agrochemicals that dragged down basic chemicals and the agri segment. However, the prioritized environmental recycling business outperformed plan on higher waste sulfuric acid intake from semiconductor manufacturers. Overall profit beat plan thanks to maintained appropriate pricing, partial price corrections, and cost reduction efforts, resulting in a 260 million yen positive contribution to ordinary income versus plan.
• Year-on-year: The segment reported a decline in both revenue and profit. While water treatment disinfectant exports grew in the basic chemicals division and environmental recycling grew year-on-year, large demand drops for core electrolytic products drove an overall revenue decline. Higher personnel costs from wage hikes, increased logistics costs from 2024 logistics industry changes, and higher raw material prices drove the year-on-year profit decline.

1. Various Salts Business:

• Against plan: Road anti-icing agents posted strong sales growth due to heavier-than-expected snowfall, driving large revenue upside. Profit also grew versus plan on the volume benefit and maintained/partially corrected pricing.
• Year-on-year: Heavier snowfall drove large year-on-year revenue growth for anti-icing agents, with profit also growing on the volume effect and appropriate pricing. Revenue contribution percentages were not explicitly provided in the transcript.

• For the FY2026 March term, management forecasts 22.9 billion yen in consolidated revenue (+9.6% year-on-year), 1.8 billion yen in operating profit (+37.8% year-on-year), and 2.2 billion yen in net income attributable to parent shareholders. The large net income increase is driven by an expected 1.2 billion yen gain from the completion of the subsidiary land sale in the term.
• The chemicals business is forecast to deliver 12.3% year-on-year revenue growth, driven by recovering sales of electrolytic products (which saw weak demand in FY2025) and partial price corrections. Price adjustments are expected to offset ongoing cost pressures from raw material, logistics, and personnel cost increases, resulting in profit growth for the segment. Ordinary profit is projected to increase by 290 million yen year-on-year overall.
• For the various salts business, management expects demand to return to normal seasonal levels after the high snowfall-driven sales in FY2025, resulting in a moderate volume decline. Maintained appropriate pricing is expected to limit the revenue and profit decline to a small single-digit percentage.
• The annual dividend is planned to increase by 5 yen to 60 yen for FY2026. The one-time profit from the land sale will be retained as internal reserve to fund future growth investment.
• The company reaffirmed its 3-year capital expenditure plan of 100 billion yen total for FY2024-FY2026, with annual investment of 30-40 billion yen, and confirmed it will make up for delayed investment from FY2025 in the remaining two plan years.

The transcript did not include any explicit discussion of material business risks or operational failures. The only cost pressures noted (ongoing raw material price increases, logistics cost increases, wage increases) are already incorporated into the FY2026 guidance.

The full transcript text provided is incomplete and only lists question topics without the actual content of the questions and management answers. The confirmed question topics are: 1) Product pricing methodology, 2) Impact of US tariff policy, 3) Impact of the subsidiary land sale, 4) Future direction of the health food business, 5) Reflections on President Sugioka's first year in office. No full exchanges are available to summarize.